Pacira BioSciences [PCRX] vs Haleon Plc – ADR [HLN] Detailed Stock Comparison

Pacira BioSciences

NASDAQ

Haleon Plc - ADR

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Pacira BioSciences wins in 9 metrics, Haleon Plc - ADR wins in 10 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Pacira BioSciences	Haleon Plc - ADR	Better
P/E Ratio (TTM)	13.14	21.82	Pacira BioSciences
Price-to-Book Ratio	1.50	5.54	Pacira BioSciences
Debt-to-Equity Ratio	83.32	53.41	Haleon Plc - ADR
PEG Ratio	-0.10	23.38	Pacira BioSciences
EV/EBITDA	8.37	36.60	Pacira BioSciences
Profit Margin (TTM)	-18.06%	13.81%	Haleon Plc - ADR
Operating Margin (TTM)	5.04%	22.21%	Haleon Plc - ADR
EBITDA Margin (TTM)	5.04%	22.21%	Haleon Plc - ADR
Return on Equity	-15.57%	9.38%	Haleon Plc - ADR
Return on Assets (TTM)	2.69%	4.61%	Haleon Plc - ADR
Free Cash Flow (TTM)	$178.75M	$2.68B	Haleon Plc - ADR
Dividend Yield	N/A	1.63%	N/A
1-Year Return	82.10%	-0.81%	Pacira BioSciences
Price-to-Sales Ratio (TTM)	1.62	4.06	Pacira BioSciences
Enterprise Value	$1.33B	$129.28B	Haleon Plc - ADR
EV/Revenue Ratio	1.88	8.72	Pacira BioSciences
Gross Profit Margin (TTM)	77.43%	55.38%	Pacira BioSciences
Revenue per Share (TTM)	$15	$2	Pacira BioSciences
Earnings per Share (Diluted)	$-2.75	$0.45	Haleon Plc - ADR
Beta (Stock Volatility)	0.48	0.24	Haleon Plc - ADR

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Pacira BioSciences vs Haleon Plc - ADR Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Pacira BioSciences	1.77%	4.28%	15.20%	-0.88%	2.34%	40.97%
Haleon Plc - ADR	0.10%	1.76%	1.76%	-11.21%	-3.25%	4.03%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Pacira BioSciences	82.10%	-52.20%	-57.50%	-56.08%	267.57%	267.57%
Haleon Plc - ADR	-0.81%	57.62%	32.52%	32.52%	32.52%	32.52%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Pacira BioSciences (PCRX): View Full Stock Overview

Haleon Plc - ADR (HLN): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Pacira BioSciences vs Haleon Plc - ADR

Metric	PCRX	HLN
Market Information
Market Cap i	$1.14B	$44.69B
Market Cap Category	Small cap	Large cap
10 Day Avg. Volume i	724,020	7,977,726
90 Day Avg. Volume i	734,633	10,685,552
Last Close	$25.84	$9.82
52 Week Range	$12.61 - $27.64	$8.86 - $11.42
% from 52W High	-6.51%	-14.01%
All-Time High	$121.95 (Feb 23, 2015)	$11.42 (Jun 02, 2025)
% from All-Time High	-78.81%	-14.01%
Growth Metrics
Quarterly Revenue Growth	0.02%	-0.01%
Quarterly Earnings Growth	0.02%	0.33%
Financial Health
Profit Margin (TTM) i	-0.18%	0.14%
Operating Margin (TTM) i	0.05%	0.22%
Return on Equity (TTM) i	-0.16%	0.09%
Debt to Equity (MRQ) i	83.32	53.41
Cash & Liquidity
Book Value per Share (MRQ)	$16.88	$1.77
Cash per Share (MRQ)	$9.92	$0.08
Operating Cash Flow (TTM) i	$134.52M	$3.34B
Levered Free Cash Flow (TTM) i	$108.49M	$2.59B
Dividends
Last 12-Month Dividend Yield i	N/A	1.63%
Last 12-Month Dividend i	N/A	$0.17

Valuation & Enterprise Metrics Analysis: Pacira BioSciences vs Haleon Plc - ADR

Metric	PCRX	HLN
Price Ratios
P/E Ratio (TTM) i	13.14	21.82
Forward P/E i	8.38	23.38
PEG Ratio i	-0.10	23.38
Price to Sales (TTM) i	1.62	4.06
Price to Book (MRQ) i	1.50	5.54
Market Capitalization
Market Capitalization i	$1.14B	$44.69B
Enterprise Value i	$1.33B	$129.28B
Enterprise Value Metrics
Enterprise to Revenue i	1.88	8.72
Enterprise to EBITDA i	8.37	36.60
Risk & Other Metrics
Beta i	0.48	0.24
Book Value per Share (MRQ) i	$16.88	$1.77

Financial Statements Comparison: Pacira BioSciences vs Haleon Plc - ADR

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	PCRX	HLN
Revenue/Sales i	$168.92M	$3.73B
Cost of Goods Sold i	$34.31M	$1.66B
Gross Profit i	$134.62M	$2.07B
Research & Development i	$25.34M	$105.46M
Operating Income (EBIT) i	$8.18M	$473.22M
EBITDA i	$39.80M	$489.44M
Pre-Tax Income i	$8.71M	$389.39M
Income Tax i	$3.89M	$89.24M
Net Income (Profit) i	$4.81M	$300.16M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	PCRX	HLN
Cash & Equivalents i	$283.61M	$2.97B
Total Current Assets i	$759.96M	$7.73B
Total Current Liabilities i	$314.73M	$7.86B
Long-Term Debt i	$424.97M	$11.65B
Total Shareholders Equity i	$798.54M	$21.94B
Retained Earnings i	$-201.54M	$36.87B
Property, Plant & Equipment i	$48.73M	$0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	PCRX	HLN
Operating Cash Flow i	$37.87M	N/A
Capital Expenditures i	$-8.55M	N/A
Free Cash Flow i	$26.91M	N/A
Debt Repayment i	$-2.81M	N/A
Common Stock Repurchase i	N/A	N/A

Short Interest & Institutional Ownership Analysis

Metric	PCRX	HLN
Shares Short i	5.69M	17.45M
Short Ratio i	9.86	1.39
Short % of Float i	0.18%	0.00%
Average Daily Volume (10 Day) i	724,020	7,977,726
Average Daily Volume (90 Day) i	734,633	10,685,552
Shares Outstanding i	46.24M	12.27B
Float Shares i	39.83M	8.95B
% Held by Insiders i	0.02%	0.00%
% Held by Institutions i	1.16%	0.13%

Dividend Analysis & Yield Comparison: Pacira BioSciences vs Haleon Plc - ADR

Metric	PCRX	HLN
Last 12-Month Dividend i	N/A	$0.17
Last 12-Month Dividend Yield i	N/A	1.63%
3-Year Avg Annual Dividend i	N/A	$0.11
3-Year Avg Dividend Yield i	N/A	0.91%
3-Year Total Dividends i	N/A	$0.34
Ex-Dividend Date	N/A	Apr 25, 2025

Pacira BioSciences [PCRX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison